The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
International harmonization of diagnostic criteria for HER2-amplified metastatic colorectal cancer and application of targeted next-generation sequencing panel as a diagnostic method.
 
Satoshi Fujii
No Relationships to Disclose
 
Anthony Martin Magliocco
No Relationships to Disclose
 
Emanuele Valtorta
No Relationships to Disclose
 
Jihun Kim
No Relationships to Disclose
 
Wataru Okamoto
Research Funding - MSD
 
Jeong Eun Kim
No Relationships to Disclose
 
Kentaro Sawada
No Relationships to Disclose
 
Yoshiaki Nakamura
Honoraria - Chugai Pharma
Other Relationship - Abbott Japan; Chugai Pharma
 
Valter Torri
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; EMD Serono; Genentech; Guardant Health (Inst); Karyopharm Therapeutics; Merck; Roche; Symphony Evolution
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Woong Yang Park
No Relationships to Disclose
 
Katsuya Tsuchihara
No Relationships to Disclose
 
Tae Won Kim
Employment - Asan Medical Center
Honoraria - AstraZeneca; Merck Serono
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - Bayer (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Salvatore Siena
No Relationships to Disclose
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)